Monitoring Gesetzessammlung

Gesetze und Verordnungen USA alphabetisch

§ 360e–3 - Breakthrough devices
21 USC 360e–3
§ 360e–4 - Predetermined change control plans for devices
21 USC 360e–4
§ 360ee - Grants and contracts for development of drugs for rare diseases and conditions
21 USC 360ee
§ 360ee–1 - FDA rare neurodegenerative disease grant program
21 USC 360ee–1
§ 360eee - Definitions
21 USC 360eee
§ 360eee–1 - Requirements
21 USC 360eee–1
§ 360eee–2 - National standards for prescription drug wholesale distributors
21 USC 360eee–2
§ 360eee–3 - National standards for third-party logistics providers
21 USC 360eee–3
§ 360eee–4 - Uniform national policy
21 USC 360eee–4
§ 360f - Banned devices
21 USC 360f
§ 360ff - Priority review to encourage treatments for rare pediatric diseases
21 USC 360ff
§ 360ff–1 - Targeted drugs for rare diseases
21 USC 360ff–1
§ 360fff - Definitions
21 USC 360fff
§ 360fff–1 - Submission of requests
21 USC 360fff–1
§ 360fff–2 - Eligibility determinations; data submission; filing
21 USC 360fff–2
§ 360fff–3 - GRASE determination
21 USC 360fff–3
§ 360fff–4 - Guidance; other provisions
21 USC 360fff–4
§ 360fff–5 - Repealed. Pub. L. 116–136, div. A, title III, § 3854(b)(5), Mar. 27, 2020, 134 Stat. 456
21 USC 360fff–5
§ 360fff–6 - Non-sunscreen time and extent applications
21 USC 360fff–6
§ 360fff–7 - Report
21 USC 360fff–7
Verwendung von Cookies.

Durch die Nutzung dieser Website akzeptieren Sie automatisch, dass wir Cookies verwenden. Cookie-Richtlinie

Akzeptieren
Markierungen
Leseansicht